A CsrA-Binding, Trans-Acting sRNA of Coxiella burnetii is Necessary for Optimal Intracellular Growth and Vacuole Formation During Early Infection of Host Cells by Wachter, Shaun et al.
Portland State University 
PDXScholar 
Biology Faculty Publications and Presentations Biology 
8-1-2019 
A CsrA-Binding, Trans-Acting sRNA of Coxiella 
burnetii is Necessary for Optimal Intracellular 
Growth and Vacuole Formation During Early 
Infection of Host Cells 
Shaun Wachter 
University of Montana, Missoula 
Matteo Bonazzi, 
Université Montpellier 
Kyle Shifflett 
University of Montana, Missoula 
Abraham Moses 
Portland State University 
Rahul Raghavan 
Portland State University, rahul.raghavan@pdx.edu 
See next page for additional authors 
Follow this and additional works at: https://pdxscholar.library.pdx.edu/bio_fac 
 Part of th  Biology Commons 
Let us know how access to this document benefits you. 
Citation Details 
Published as: Wachter, S., Bonazzi, M., Shifflett, K., Moses, A. S., Raghavan, R., & Minnick, M. F. (2019). A 
CsrA-binding, trans-acting sRNA of Coxiella burnetii is necessary for optimal intracellular growth and 
vacuole formation during early infection of host cells. Journal of bacteriology, JB-00524. 
This Post-Print is brought to you for free and open access. It has been accepted for inclusion in Biology Faculty 
Publications and Presentations by an authorized administrator of PDXScholar. For more information, please contact 
pdxscholar@pdx.edu. 
Authors 
Shaun Wachter; Matteo Bonazzi,; Kyle Shifflett; Abraham Moses; Rahul Raghavan; and Michael F. Minnick 
This post-print is available at PDXScholar: https://pdxscholar.library.pdx.edu/bio_fac/276 
A CsrA-binding, trans-acting sRNA of Coxiella burnetii is necessary for optimal intracellular1 
growth and vacuole formation during early infection of host cells 2 
3 
Shaun Wachter
1
, Matteo Bonazzi
2
, Kyle Shifflett
1
, Abraham S. Moses
3†
, Rahul Raghavan
3
, and4 
Michael F. Minnick
1*
5 
6 
1 
Program in Cellular, Molecular and Microbial Biology, Division of Biological Sciences,7 
University of Montana, Missoula, Montana, USA 8 
2 
CNRS, UMR5236, CPBS, Montpellier, France, Université Montpellier 1, CPBS, Montpellier,9 
France, Université Montpellier 2, CPBS, Montpellier, France   10 
3 
Department of Biology and Center for Life in Extreme Environments, Portland State 11 
University, Portland, Oregon, USA  12 
13 
Running Head: Roles of a Coxiella burnetii Infection-Specific sRNA 14 
15 
* Address correspondence to Michael F. Minnick, mike.minnick@mso.umt.edu16 
† 
Present address: College of Pharmacy, Oregon State University, Corvallis, Oregon, USA17 
18 
19 
20 
Abstract 21 
JB Accepted Manuscript Posted Online 26 August 2019
J. Bacteriol. doi:10.1128/JB.00524-19
Copyright © 2019 American Society for Microbiology. All Rights Reserved.
2 
Coxiella burnetii is an obligate intracellular gammaproteobacterium and zoonotic agent of Q22 
fever. We previously identified 15 small non-coding RNAs (sRNAs) of C. burnetii. One of them,23 
CbsR12 (Coxiella burnetii small RNA 12), is highly transcribed during axenic growth and24 
becomes more prominent during infection of cultured mammalian cells. Secondary structure25 
predictions of CbsR12 revealed four putative CsrA-binding sites in stem loops with consensus26 
AGGA/ANGGA motifs. We subsequently determined that CbsR12 binds to recombinant C.27 
burnetii CsrA-2, but not CsrA-1, proteins in vitro. Moreover, through a combination of in vitro28 
and cell culture assays, we identified several in-trans mRNA targets of CbsR12. Of these, we29 
determined that CbsR12 binds and upregulates translation of carA transcripts coding for30 
carbamoyl phosphate synthetase A; an enzyme that catalyzes the first step of pyrimidine 31 
biosynthesis. In addition, CbsR12 binds and downregulates translation of metK transcripts32 
coding for S-adenosyl methionine (SAM) synthetase, a component of the methionine cycle.33 
Furthermore, we found that CbsR12 binds to and downregulates the quantity of cvpD transcripts,34 
coding for a type IVB effector protein, in mammalian cell culture. Finally, we found that CbsR1235 
is necessary for expansion of Coxiella-containing vacuoles (CCVs) and affects growth rates in a 36 
dose-dependent manner in the early phase of infecting THP-1 cells. This is the first37 
characterization of a trans-acting sRNA of C. burnetii and first example of a bacterial sRNA that38 
regulates both CarA and MetK synthesis. CbsR12 is one of only a few identified trans-acting39 
sRNAs that interacts with CsrA. 40 
41 
Importance 42 
Regulation of metabolism and virulence in C. burnetii is not well understood. Here, we show43 
that C. burnetii small RNA 12 (CbsR12) is highly transcribed in the metabolically active large-44 
3 
cell variant (LCV) compared to the non-replicative small-cell variant (SCV). We show that45 
CbsR12 directly regulates several genes involved in metabolism, along with a type IV effector46 
gene, in trans. Additionally, we demonstrate that CbsR12 binds to CsrA-2 in vitro and induces47 
autoaggregation and biofilm formation when transcribed ectopically in Escherichia coli,48 
consistent with other CsrA-sequestering sRNAs. These results implicate CbsR12 in the indirect 49 
regulation of a number of genes via CsrA-mediated regulatory activities. The results also support50 
CbsR12 as a crucial regulatory component early on in a mammalian cell infection. 51 
52 
Introduction 53 
Coxiella burnetii is a Gram-negative, obligate intracellular bacterium and etiological agent54 
of Q fever in humans. Q fever most often manifests as an acute, flu-like illness, which in rare55 
cases progresses to potentially life-threatening endocarditis (1). C. burnetii undergoes a biphasic56 
life cycle in which it alternates between a metabolically-active, replicative large-cell variant57 
(LCV) and a non-replicative, spore-like small-cell variant (SCV) (2). Upon aerosol transmission58 
of SCVs to a mammalian host, C. burnetii is primarily endocytosed by alveolar macrophages,59 
after which it survives acidification of the host phagolysosome and metamorphoses to LCVs. C.60 
burnetii then utilizes the fusion of its Coxiella-containing vacuole (CCV) with lysosomes and61 
autophagosomes in order to expand the intracellular niche (3, 4). CCV expansion is dependent on62 
C. burnetii protein synthesis, but independent of replication, so expansion of the CCV is63 
facilitated by a repertoire of Dot/Icm effector proteins secreted by a Type IV-B secretion system 64 
(T4BSS) (5, 6). Many Dot/Icm substrates have been identified in recent years (7) and shown to65 
modulate the host inflammasome (8), influence autophagosomal/lysosomal fusion with the CCV66 
by various mechanisms (9-13), and regulate the host transcriptome after localizing to the nucleus67 
4 
(14, 15). Little is known about regulation of C. burnetii’s T4BSS, although the PmrA response68 
regulator has been shown to enhance synthesis of the T4BSS apparatus as well as certain69 
Dot/Icm substrates (16). 70 
Bacterial sRNAs are small (<500 nts) transcripts that usually do not code for functional71 
proteins. Instead, they serve as cis- and/or trans-acting regulators through a variety of72 
mechanisms (reviewed in (17)). For example, cis-acting sRNAs are often coded antisense to a 73 
functional gene target. Upon transcription, the sRNA binds to the mRNA with perfect 74 
complementarity, usually culminating in ribonuclease degradation of the target. This effectively75 
limits the free mRNA molecules available for translation (reviewed in (18)). Alternatively, trans-76 
acting sRNAs are often coded in distant intergenic regions (IGRs) and bind to a variety of77 
mRNAs through a more limited base-pairing mechanism involving a seed region of ~7 - 12 nts.78 
Many trans-acting sRNAs have been discovered in bacteria since Escherichia coli MicF was79 
first described in 1984 (19). These regulatory RNAs have been implicated in a variety of80 
processes, including virulence (20), global regulation of transcription (21), iron homeostasis81 
(22), protein degradation (23), and stress response (24, 25).  82 
Typically, trans-acting sRNAs require assistance in “finding” their respective mRNA83 
targets. In most bacteria, this is accomplished by the RNA chaperone Hfq, which binds to both84 
sRNAs and mRNAs and plays the role of a molecular matchmaker (reviewed in (26)). Hfq is not85 
obligatory, however. For example, Staphylococcus aureus has several sRNAs but does not86 
require Hfq protein for their activities (27). Similarly, C. burnetii does not have a readily87 
apparent hfq gene, although this doesn't rule out the possibility of an atypical Hfq or some other 88 
novel RNA chaperone.  89 
5 
Some sRNAs act by binding to and titrating RNA-binding proteins, effectively sequestering90 
them away from regulatory activities. For instance, C. burnetii codes for two homologs (CsrA-1,91 
CsrA-2) of the RNA-binding protein CsrA (RsmA), which has been shown to regulate92 
metabolism, biofilm formation, and Type 4 secretion in other bacteria (28-30). CsrA is, in turn, 93 
regulated by CsrA-binding sRNAs, termed CsrB/C (RsmY/Z). Classical CsrB/C sRNAs consist94 
of a series of stem-loops containing exposed AGGA or ANGGA motifs that bind and sequester95 
CsrA, effectively limiting its mRNA regulatory capabilities (31). Some RsmY/Z sRNAs, 96 
however, differ in the number of stem-loop regions containing CsrA-binding sites and can harbor 97 
far fewer motifs than the classical CsrB/C counterparts of E. coli (32, 33). The CsrA regulatory98 
cascade has not been studied in C. burnetii, in large part due to the absence of readily-discernible 99 
RsmY/Z sRNAs, although the CsrA regulon in Legionella pneumophila, a close relative of C.100 
burnetii, has been extensively studied (34, 35). 101 
A previous study by our group revealed 15 novel C. burnetii sRNAs that were differentially102 
transcribed either in LCVs vs. SCVs, or in host cell infections vs. growth in ACCM-2 medium 103 
(36, 37). Among these, CbsR12 was found to be markedly upregulated in the intracellular niche104 
as compared to ACCM-2. Northern blots also showed that CbsR12 was upregulated in SCVs vs.105 
LCVs in ACCM-2, and revealed two distinct sizes of the sRNA, suggesting that either an 106 
alternative transcription start site (TSS) or ribonuclease processing of the sRNA was responsible.107 
In a subsequent study, CbsR3 and CbsR13 were found to originate from transcribed loci of a108 
selfish genetic element, termed QMITE1 (38). However, despite the identification and109 
verification of several CbsRs, none has been functionally characterized, to date. 110 
In this study, we describe activities of a highly transcribed, infection-specific sRNA of C.111 
burnetii, termed CbsR12. Our analyses show that CbsR12 binds to CsrA-2, but not CsrA-1 in112 
6 
vitro. We also establish that CbsR12 binds and up-regulates carA (CBU_1282) and down-113 
regulates metK (CBU_2030) transcripts, in trans. The bacterial carA gene codes for carbamoyl-114 
phosphate synthetase (small) subunit A (CarA), which forms a heterodimer with carbamoyl-115 
phosphate synthetase (large) subunit B (CarB). The CarAB complex catalyzes the first step in116 
pyrimidine biosynthesis and is involved in arginine biosynthesis in some bacteria (39). The117 
bacterial metK gene codes for S-adenosyl L-methionine (SAM) synthetase, an enzyme118 
responsible for catalyzing production of SAM, the major donor of methyl groups during119 
metabolism in prokaryotic cells. As a methyl donor, SAM affects DNA methylation and thus120 
global transcription (40). It has also been implicated in virulence, being necessary for the121 
production of N-acyl homoserine lactones involved in bacterial quorum sensing (reviewed in122 
(41)). We also implicate CbsR12 in expansion of the CCV, as its size is directly correlated with123 
levels of the sRNA. Furthermore, we find that CbsR12 binds ahcY (CBU_2031) and cvpD124 
(CBU_1818) transcripts, which are components of the methionine cycle and a T4BSS effector125 
protein, respectively (9). Overall, this study highlights CbsR12 as a crucial component in early126 
stages of a Coxiella infection.  127 
128 
Results 129 
CbsR12 is a principal non-rRNA/tRNA/tmRNA transcript during C. burnetii infection of130 
Vero and THP-1 cells 131 
CbsR12 was first described as a highly-transcribed, infection-specific sRNA that was132 
upregulated in SCVs compared to LCVs when analyzed by Northern blots (36). The impetus for 133 
our study came when we analyzed previous RNA-Seq data (SRP041556) (36) by converting raw134 
read data into transcripts per million (TPM), a normalized measure of gene expression (42).135 
7 
These results showed that CbsR12 was the most highly transcribed non-tmRNA transcript in136 
both LCVs and SCVs during C. burnetii infection of African green monkey kidney epithelial137 
cells (Veros). Additional data from LCVs obtained from a C. burnetii infection of monocytic138 
THP-1 cells corroborates the observation that CbsR12 is a principal transcript during infection 139 
(Rahul Raghavan, unpublished data). Moreover, we were surprised to find that CbsR12 was140 
more abundant in LCVs, not SCVs (Table 1).  141 
CbsR12 is processed by ribonuclease III in vitro 142 
Previous Northern blot analyses showed that CbsR12 produced two bands of approximately 170 143 
and 50 nucleotides, regardless of C. burnetii growth conditions or developmental stage (36). We144 
therefore wished to determine whether these RNAs arose from alternative TSSs for the cbsR12 145 
gene or from ribonuclease III (RNase III) processing of the full-length CbsR12 transcript. We146 
first utilized 5' rapid amplification of cDNA ends (RACE) with total RNA derived from C.147 
burnetii LCVs infecting Veros (3dpi) in order to determine the TSS of CbsR12. This experiment 148 
revealed the full-size CbsR12 (~200 nucleotides) as expected, but also indicated that two149 
potential alternative TSSs existed ~110 nucleotides upstream of the cbsR12 gene’s Rho-150 
independent terminator (Fig. S1A). To determine whether the TSSs were generated by RNase-151 
mediated cleavage, we treated in vitro-transcribed CbsR12 with recombinant C. burnetii RNase 152 
III (43) and commercially-available E. coli RNase III (New England BioLabs). Results showed 153 
that CbsR12 was similarly processed by both kinds of RNase III into two RNA fragments with 154 
sizes that closely resembled those in the previously-reported Northern blot analysis (Fig. S1B)155 
(36). These results strongly suggest that the two sites are not alternative TSSs but are instead156 
generated by RNase III processing. 157 
CbsR12 binds to C. burnetii recombinant CsrA-2, but not CsrA-1, in vitro 158 
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8 
The predicted secondary structure of CbsR12 also revealed four conserved single-strand159 
sequence motifs among the various stem-loop structures (Fig. S1A). This motif,160 
AGGA/ANGGA, corresponds exactly to the conserved CsrA-binding motif of many bacteria161 
(30, 32). C. burnetii contains two annotated and distinct types of CsrA (termed CsrA-1162 
[CBU_0024] and CsrA-2 [CBU_1050]) that share 65% primary sequence identity. To test the163 
functionality of these domains, we employed an in vitro binding assay and a RNA-protein164 
electrophoretic mobility shift assay (EMSA) to determine if CbsR12 binds to natively-purified 165 
recombinant CsrA-1 (rCsrA1) and/or CsrA-2 (rCsrA-2). EMSA results clearly showed that166 
CbsR12 binds to rCsrA-2, but not rCsrA-1, in vitro (Fig. 1). In addition, a CbsR10 negative-167 
control sRNA did not bind either rCsrA. Furthermore, the KD for rCsrA-2 was determined to be 168 
130 nM, consistent with published values for CsrA-binding sRNAs (44). 169 
A cbsR12 mutant shows prolonged lag phase in axenic media 170 
A cbsR12 mutant of C. burnetii (strain RSA439 with Tn 327, hereafter referred to as MB-171 
cbsR12), as well as an otherwise isogenic transposon insertional control strain (strain RSA439172 
with Tn 1832, hereafter referred to as MB-WT), were previously generated using a Himar1-173 
based transposon system (11). The location of the transposon insertion of strain MB-cbsR12 is174 
shown in Fig. S2A. We also constructed a transposon-directed complement of strain MB-cbsR12 175 
(hereafter referred to as MB-cbsR12-Comp) containing the wild-type cbsR12 gene plus ~100 bp176 
of 5' and 3' flanking sequences, to include any potential transcriptional regulator element(s) that177 
could influence cbsR12 expression. PCR was used to confirm the transposon insertions in the 178 
MB-cbsR12 and MB-cbsR12-Comp (Fig. S2B). Furthermore, we confirmed that the cbsR12 179 
cassette inserted into an intergenic region between CBU_1788 and CBU_1789 (RSA493: 180 
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9 
accession number NC_002971.4), and we utilized copy-number quantitative PCR (qPCR) to181 
confirm the single insertional event in MB-cbsR12-Comp (S2C Fig). 182 
Next, we conducted growth curve analyses of MB-WT, MB-cbsR12, and MB-cbsR12-Comp 183 
strains grown axenically in ACCM-2 (Figs. 2A, S3A, S3B) and assayed production of CbsR12 at 184 
incremental time points from the LCV stage (~ 1-6 d) through the SCV stage (>7 d) by 185 
quantitative real-time PCR (qRT-PCR) (Fig. 2B). Growth curve results showed that MB-cbsR12 186 
displayed a prolonged lag phase from 1-3 d post-inoculation that was not observed in MB-WT or187 
MB-cbsR12-Comp strains (Figs. 2A, S3A, S3B). Following lag phase, MB-cbsR12 grew at a 188 
slightly increased rate relative to the other strains (6-9 d post-infection), but failed to reach cell189 
numbers seen in the other two strains throughout the assay. The “wild-type” (MB-WT) and190 
complemented (MB-cbsR12-Comp) strains produced essentially indistinguishable growth curves.191 
The qRT-PCR results showed that the Tn insertion in MB-cbsR12 completely abrogated CbsR12192 
production (Fig. 2B). The results also confirmed cbsR12’s increased expression in LCVs193 
compared to SCVs as copies of CbsR12 per C. burnetii genome were highest at 3 d post-194 
inoculation. 195 
CbsR12 impacts intracellular replication of C. burnetii 196 
C. burnetii typically infects alveolar macrophages during human infection. We therefore infected197 
a differentiated human monocyte cell line (THP-1) with MB-WT, MB-cbsR12, and MB-cbsR12-198 
Comp strains. Comparative growth curves showed that MB-cbsR12 has a slower growth rate in 199 
exponential phase (1-3dpi) as compared to the two other strains, and never attained the bacterial200 
cell numbers seen in infections with MB-WT or MB-cbsR12-Comp (Figs. 3A, S3C, S3D).201 
Furthermore, CbsR12 production in THP-1s correlated with replication efficiency of the202 
individual strain. For example, production of CbsR12 in MB-WT and MB-cbsR12-Comp strains203 
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10 
increased between 1dpi and 3dpi, and CbsR12 levels directly correlated to growth rates of the 204 
respective strains between these two time points. However, we observed a dysregulation of 205 
CbsR12 in MB-cbsR12-Comp infecting THP-1 cells that was strikingly different than what was 206 
seen during axenic growth. Specifically, we observed a maintenance of CbsR12 production 207 
throughout infection of THP-1s (Fig. 3B), whereas in axenic growth there was a progressive208 
drop-off in synthesis after 3dpi (see Fig. 2B). These results suggest that cbsR12 expression209 
differs in this host-cell type and that a transcriptional regulatory motif may exist outside the210 
bounds of the complementation insertion, resulting in dysregulation due to the genomic context 211 
of cbsR12 in MB-cbsR12-Comp compared to MB-WT in a THP-1 infection. 212 
CCV size correlates with CbsR12 production in THP-1 infection 213 
To more closely examine bacterial-host cell interactions, we employed immunofluorescence214 
assays (IFAs) of C. burnetii infecting THP-1 cells. C. burnetii colonies and CCV boundaries215 
were visualized using anti-Coxiella (anti-Com1 (45)) and anti-LAMP1 antibodies at both 3dpi 216 
(late LCVs) and 7dpi (SCVs). Here, we define a C. burnetii colony as multiple C. burnetii 217 
inhabiting a LAMP1-decorated intracellular vacuole. LAMP1 is a host cell protein recruited to218 
lysosomes and found on CCVs after lysosome fusion (46). We observed a robust infection at219 
3dpi for MB-WT and MB-cbsR12-Comp strains, whereas the MB-cbsR12 strain only produced a220 
few, small CCVs with relatively unclear boundaries (Fig. 4A). In contrast, the MB-cbsR12-221 
Comp strain produced CCVs that were similar in size to those generated by the MB-WT strain,222 
reflecting the trend observed in their respective growth curves (see Fig. 3A). Quantitatively,223 
differences in CCV sizes between MB-cbsR12 and the other two strains were significant at 3dpi 224 
(Fig. 4B). However, by 7dpi the CCVs were of similar size in MB-cbsR12 and MB-WT 225 
infections, indicating some compensatory or redundant mechanisms allowing for CCV expansion 226 
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 11 
as the infection proceeded, even though MB-cbsR12 genome counts never reached wild-type 227 
levels (see Fig. 3A). Interestingly, the MB-cbsR12-Comp strain formed consistently larger CCVs 228 
at 3dpi (significantly greater than MB-WT and MB-cbsR12) and 7dpi (significantly greater than 229 
MB-cbsR12), which meshes well with the sustained expression of cbsR12 evidenced throughout 230 
the course of infection (see Fig. 3B). Taken as a whole, these results suggest that CbsR12 is 231 
important for optimum growth and establishment of CCVs early in the course of infection of 232 
THP-1 cells, and CbsR12 can influence CCV expansion throughout a THP-1 infection.  233 
CbsR12 binds to carA, metK, and cvpD transcripts in vitro 234 
Although CbsR12 was identified as a CsrA-binding sRNA, nothing was known about the CsrA 235 
regulon in C. burnetii, making it difficult to ascribe intracellular phenotypes to regulation by 236 
CsrA. Therefore, we wanted to determine if CbsR12 could act by regulating mRNAs in trans. To 237 
identify potential mRNA targets of CbsR12, we first employed three in silico sRNA target 238 
discovery algorithms. Each algorithm takes into consideration the extent of sRNA-mRNA 239 
hybridization, conservation of the sRNA, and the accessibility of both the sRNA and its target, 240 
although TargetRNA2 and IntaRNAv2 prioritize accessibility while CopraRNA prioritizes 241 
comparative interaction predictions among different strains of the indicated bacterium. From 242 
these search results, we omitted genes annotated as hypothetical and chose cvpD, metK, carA, 243 
purH, rpsA, and dnaA as potential targets based on conserved predictions (Table 2). To get a 244 
sense of CbsR12’s ability to bind to these potential mRNA targets, we next performed a RNA-245 
RNA hybridization followed by EMSAs. The results clearly showed that CbsR12 bound to carA, 246 
metK, and cvpD transcripts in vitro, but did not interact with rpsA, purH, or dnaA mRNAs (Fig. 247 
5). We further tested CbsR12’s specificity for these transcripts by performing dose-dependent 248 
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 12 
and unlabeled-chase experiments. Results of the EMSA analyses showed that CbsR12 249 
specifically bound carA, metK, and cvpD transcripts in a dose-dependent manner (Fig. S4).  250 
CbsR12 binds to metK, carA, cvpD, and ahcY transcripts in C. burnetii cells 251 
To determine the CbsR12 targetome within C. burnetii cells, we employed a Crosslink-Seq 252 
technique previously used to detect intracellular mRNA targets of E. coli sRNAs (47). For this 253 
procedure, we used C. burnetii LCVs grown in ACCM-2 to produce sufficient volumes to 254 
capture CbsR12 target RNAs for cDNA library preparation and RNA-Seq analysis. Hybridized 255 
RNAs in lysates from both MB-WT and MB-cbsR12 strains were chemically cross-linked, 256 
captured by anti-CbsR12 probes, and analyzed by RNA-Seq in order to identify RNAs enriched 257 
in MB-WT compared to MB-cbsR12. Crosslink-Seq results confirmed that CbsR12 targeted 258 
carA, metK, and cvpD transcripts in C. burnetii cells (Fig. 6), as demonstrated in vitro (see Fig. 259 
5). We also discovered an additional mRNA target, ahcY, coding for adenosylhomocysteinase, 260 
another component of the methionine cycle. Interestingly, ahcY was also predicted as an mRNA 261 
target by IntaRNA, although the p-value was not significant (p = 0.13). Additionally, ahcY is in 262 
an operon with and downstream of metK. To address whether ahcY is actually a target of 263 
CbsR12, or if it is a result of CbsR12’s binding to a polycistronic mRNA, we used the Artemis 264 
genome browser to observe Crosslink-Seq reads aligned to the C. burnetii RSA439 genome. This 265 
analysis showed distinct segments of these genes to which the captured reads mapped, 266 
suggesting they are separate binding events (Fig. S5B). We also confirmed the other identified 267 
targets by the same method (Fig. S5A, S5C). 268 
 Next, we wanted to determine whether CbsR12-mediated regulation of predicted in-trans 269 
mRNA targets would occur independently of CsrA. To this end, we searched for potential CsrA-270 
binding (AGGA/ANGGA) motifs within the 100 bases up and downstream of the start codons of 271 
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 13 
carA, metK, cvpD, and ahcY. This search showed that carA, metK and cvpD contained single 272 
potential CsrA-binding sites whereas cvpD had none. Moreover, the motifs of carA and metK did 273 
not occur in predicted ribosome-binding sites (RBS), suggesting that CsrA is unlikely to regulate 274 
the corresponding transcripts (35) (Table 3). Thus, CbsR12 regulation of carA, metK, and cvpD 275 
transcripts likely occurs as a direct result of in-trans binding by CbsR12 and independently of 276 
CsrA. In contrast, the ahcY sequence has two potential regulatory ANGGA CsrA-binding sites, 277 
so we cannot exclude the possibility of indirect regulatory effects caused by CbsR12-mediated 278 
sequestering of CsrA. As such, we did not further explore CbsR12-mediated regulation of ahcY. 279 
CbsR12 negatively affects the quantity of cvpD transcripts and regulates synthesis of CarA 280 
and MetK  281 
Next, we set out to determine if CbsR12 regulates carA, metK, and cvpD transcripts in C. 282 
burnetii. First, we performed 5' RACE on the three transcripts in total RNA extracted from LCVs 283 
infecting mammalian cells (3dpi). 5' RACE results for the MB-WT cvpD gene indicated three 284 
apparent TSSs, including a TSS for the full-length transcript, several questionable “TSSs” within 285 
the CbsR12-binding site, and an alternative TSS for a short transcript downstream of the 286 
CbsR12-binding site and with its own predicted promoter element (Fig. S6A). Interestingly, 287 
putative RBSs and start codons exist downstream of TSSs for both the full-length and short 288 
transcripts. Moreover, the two start codons are in-frame with each other and the existence of 289 
putative RBSs supports the possibility that translation occurs from both elements. The 290 
questionable “TSSs” within the CbsR12-binding region likely result from CbsR12-mediated 291 
RNase III degradation of cvpD mRNA, because 5' RACE results for MB-cbsR12, a strain that 292 
lacks CbsR12, did not produce TSSs in this region. We predict that CbsR12 down-regulates 293 
production of full-length CvpD since the CbsR12-binding site occurs in the coding region. 294 
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 14 
However, CbsR12 would predictably have no effect on production of the putative truncated 295 
CvpD, as the CbsR12-binding site occurs upstream of the alternative TSS (Figs. S6A, S6B).  296 
To determine if CbsR12 binds to and causes degradation of full-length cvpD transcripts, we 297 
performed qRT-PCR on MB-WT, MB-cbsR12, and MB-cbsR12-Comp LCVs obtained from 298 
infected THP-1 cells. These results clearly showed that the absence of CbsR12 in strain MB-299 
cbsR12 led to a significant increase in full-length cvpD transcripts in LCVs (3dpi) (Fig. S6C). At 300 
7dpi, MB-WT and MB-cbsR12 levels were not significantly different, presumably due to 301 
reduced CbsR12 production in MB-WT SCVs (see Fig 3B). However, cvpD expression was 302 
significantly lower in MB-cbsR12-Comp, most likely due to the maintained production of 303 
CbsR12 in the strain’s SCVs (see Fig 3B). Whether or not two different forms of CvpD are 304 
produced from cvpD is unknown, although it appears that CbsR12 may negatively regulate the 305 
full-length cvpD transcript. 306 
In order to determine if CbsR12 binds to and regulates carA and metK in a cellular 307 
environment, we devised a reporter assay in E. coli that measures the effects of CbsR12 308 
production on translation of carA-luc or metK-luc fusion constructs. 5' RACE results for both 309 
MB-WT and MB-cbsR12 strains revealed that carA has two potential TSSs, a finding that is 310 
consistent with transcription of E. coli carA (39). Based on the position of the TSSs, CbsR12 311 
could only regulate the full-length carA transcript and not the shorter mRNA, whose 312 
transcription starts immediately upstream of the RBS and downstream of the CbsR12-binding 313 
site (Fig. 7A). From these results, we hypothesized that CbsR12 binds to the 5' untranslated 314 
region (UTR) of carA and upregulates translation by relieving the secondary structure that 315 
occludes the predicted RBS (Figs. 7A, 7B). Results of the E. coli reporter assay confirmed our 316 
hypothesis, because translation of luciferase enzyme from a carA5'UTR-luc fusion was 317 
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significantly upregulated in the presence of CbsR12 relative to a strain lacking the sRNA (Fig. 318 
7C). 319 
In contrast, CbsR12 was predicted to downregulate MetK translation by binding to the 320 
coding region of the transcript, immediately downstream of its start codon (Fig. 8A). As is often 321 
the case with this type of sRNA-mediated regulation, RNase III would likely be recruited and the 322 
metK transcript cleaved, resulting in downregulation of the encoded protein product. 323 
Unexpectedly, 5' RACE analyses of metK mRNA also identified apparent alternative “TSSs” 324 
within the CbsR12-binding region, suggesting that the truncated mRNAs resulted from CbsR12-325 
mediated RNase III processing (Figs. 8A, 8B). Indeed, 5' RACE analysis of RNA from strain 326 
MB-cbsR12 infecting THP-1 cells did not detect the “TSSs”, suggesting they are a product of 327 
RNase III processing. Results of the reporter assays in E. coli confirmed our hypothesis, as the 328 
presence of CbsR12 significantly down-regulated translation of luciferase from the metK-luc 329 
fusion construct compared to a strain lacking the sRNA (Fig. 8C). 330 
 Although we determined that CbsR12 targets carA and metK transcripts in vitro and in E. 331 
coli, we were curious whether the absence of CbsR12 would also result in differential amounts of 332 
CarA and MetK proteins in C. burnetii. To this end, we performed Western blots with polyclonal 333 
antibody generated against recombinant C. burnetii CarA and MetK. As predicted, when proteins 334 
from whole-cell lysates of MB-WT, MB-cbsR12, and MB-cbsR12-Comp strains were compared, 335 
we found that CarA was synthesized in MB-WT and MB-cbsR12-Comp strains at comparable 336 
levels, but was undetectable in protein profiles of strain MB-cbsR12 (Figs. 9A, S7A). In sharp 337 
contrast, MetK was highly synthesized in strain MB-cbsR12 but was produced at relatively lower 338 
and comparable levels in the MB-WT and MB-cbsR12-Comp strains (Figs. 9B, S7B). 339 
 340 
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Discussion 341 
In this report, we show that CbsR12, a multifunctional sRNA that binds to mRNAs and to the 342 
regulatory protein CsrA-2, is important for proper Coxiella replication and CCV expansion 343 
during infection of human macrophage-like THP-1 cells. Induction of cbsR12 expression in 344 
mammalian cell culture vs. in vitro conditions (see Table 1) led us to label CbsR12 as 345 
“infection-specific” and as a result we hypothesized that it played an important regulatory role in 346 
infection of host cells. The cbsR12 sequence is conserved among all C. burnetii strains 347 
sequenced to date, underscoring the potential for an important regulatory role, but from an 348 
evolutionary viewpoint. Interestingly, though, the cbsR12 gene is missing or degenerate in 349 
Coxiella-like endosymbionts (48), suggesting that the sRNA is important for a mammalian 350 
infection but is dispensable in endosymbionts that reside in arthropods. 351 
 Interestingly, CbsR12 binds rCsrA-2, but not rCsrA-1, in a dose-dependent manner, in vitro. 352 
Why CsrA-1 does not bind to consensus motifs present in CbsR12  is unclear, especially since 353 
both CsrA-1 and CsrA-2 maintain the critical L4 and R44 RNA-binding residues, although 354 
CsrA-1 has these residues at L4 and R46 (49). There are several examples of pathogens 355 
harboring multiple copies of CsrA (50, 51). For example, RsmF of P. aeruginosa is a homolog of 356 
RsmA (CsrA) and functions by binding a subset of mRNAs that RsmA also binds (51). 357 
However, an rsmF mutant did not display a phenotype during infection (51). Similarly, In C. 358 
burnetii, a transposon-mediated csrA-1 mutant was shown to have no intracellular phenotype 359 
(12). It is also conceivable that CsrA-1 diverged during C. burnetii’s adaptation to an 360 
intracellular lifestyle and is no longer functional. It is also possible that CsrA-1 binds to a non-361 
canonical motif not present in CbsR12, although such CsrA homologs have not been described, 362 
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17 
to our knowledge. Regardless, it is necessary to examine the CsrA-1 and CsrA-2 regulons in363 
order to determine their respective roles during infection. 364 
In L. pneumophila, a close relative of C. burnetii, successful infection depends on a LetAS-365 
RsmYZ-CsrA regulatory cascade. LetAS is a two-component system (TCS) that regulates366 
production of two sRNAs, RsmY and RsmZ, which in turn act as RNA “sponges” that soak up 367 
CsrA and modulate its activity (35). We determined that CbsR12 possesses only four CsrA-368 
binding sites, similar to the RsmY/Z sRNAs of L. pneumophila. Interestingly, L. pneumophila369 
RsmY/Z was implicated in the formation of cell aggregates and biofilms when the sRNAs were 370 
ectopically overproduced in E. coli, mimicking the effects of E. coli's own CsrA-binding sRNAs371 
(33). Likewise, when we overproduced CbsR12 in E. coli reporter assays (Figs. 7, 8), we372 
observed a similar autoaggregative phenotype (Fig. S8A). Moreover, CbsR12 induced biofilm 373 
production in E. coli, reflecting a CsrA-depleting phenotype (Fig. S8B). Together, these results374 
suggest that CbsR12 is a CsrA-sequestering, RsmY/Z-like sRNA, although further research is375 
necessary to determine the exact influence of CbsR12 on the regulatory roles of CsrA-2. 376 
C. burnetii has several potential transcription factors that are known to upregulate bacterial377 
expression, including Integration Host Factor (IHF) (52), response regulator PmrA (53), and378 
transcription factor DksA (54). However, only PmrA has been well-studied, to date (16). It is379 
interesting to note that the cbsR12 gene contains a close approximation to a PmrA-binding site380 
(consensus sequence with less conserved nucleotides in lowercase: cTTAA-N2-TT-N2-cTTAA)381 
(55) immediately upstream of its predicted -10 promoter element (cbsR12 sequence: gTTTA-N2-382 
TT-N1-gTTAA). However, the presence of this sequence does not explain the prolonged CbsR12383 
production observed during a THP-1 infection by MB-cbsR12-Comp since the putative PmrA-384 
binding sequence is present in the cbsR12 cassette that was inserted. We predict that expression385 
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of cbsR12 is regulated by an unidentified TCS in a fashion similar to the L. pneumophila LetAS 386 
TCS regulation of RsmYZ sRNAs (35). In fact, the LetAS TCS is not unlike the GacAS TCS 387 
involved in RsmYZ-CsrA cascades of other bacteria (56). C. burnetii codes for four different 388 
GacA response regulators that could bind upstream elements of cbsR12 and regulate its 389 
expression (57). This upstream regulator may, in turn, help to explain the dysregulation of 390 
expression seen in MB-cbsR12-Comp during infection of THP-1 cells (see Fig. 3B) that is not 391 
apparent during axenic growth (see Fig. 2B). Alternatively, expression of cbsR12 could be 392 
upregulated by PmrA, and some other regulator may be involved in its down-regulation, in 393 
conjunction with RNase III-mediated decay (see Fig. S1). Together, these would aid in 394 
suppression of CbsR12 as the LCV-to-SCV transition occurs, effectively freeing sequestered 395 
CsrA-2 to regulate the fate of target transcripts. 396 
It is worth noting that we have identified a second sRNA, Coxiella burnetii small RNA 1 397 
(CbsR1), that possesses 5 putative CsrA-binding sites with an ANGGA motif (Fig. S9B) (36). 398 
Similar to Cbsr12, CbsR1 is also produced at high levels in LCVs infecting Vero cells (see 399 
Table 1). Furthermore, cbsR1 harbors a putative LetA-binding site similar to that of L. 400 
pneumophila RsmY (Fig. S9A) (33). Together, these observations suggest that CbsR1 and 401 
CbsR12 may represent orthologs of RsmYZ, although further exploration of CbsR1 and its 402 
cooperativity with CbsR12 is required. If CbsR1 does indeed serve as a CsrA-binding sRNA, its 403 
potential, redundant regulatory role may help to explain why MB-cbsR12 CCVs expanded to 404 
wild-type sizes as the infection progressed (see Fig. 4B). 405 
We also found that CbsR12 binds carA transcripts (see Figs. 5, 7) and upregulates 406 
production of C. burnetii CarA (see Fig. 9A). Pyrimidine metabolism in C. burnetii presumably 407 
requires CarAB to catalyze the conversion of L-glutamine into carbamoyl phosphate and 408 
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glutamate, since it is unable to shunt this process through the arginine dihydrolase pathway; C.409 
burnetii apparently lacks the necessary enzymes (58). CbsR12-mediated upregulation of CarA in410 
LCVs would result in increased production of pyrimidines that the pathogen requires for robust 411 
intracellular growth. 412 
In E. coli, carA expression is tightly controlled by a series of transcriptional regulators and413 
the two distinct promoters that are regulated by feedback from arginine and pyrimidines (39). 5' 414 
RACE analysis showed two distinct TSSs for C. burnetii carA mRNA, with the full-length415 
transcript containing two CbsR12-binding sites and a shorter putative transcript lacking the site 416 
(see Fig. 7A). We do not believe that the shorter, alternative TSS is due to RNase III-mediated417 
degradation resulting from CbsR12 binding because this alternative TSS remained in 5' RACE418 
analysis of the MB-cbsR12 strain. We do not know conditions under which the shorter transcript419 
is produced, but it may involve feedback from arginine/pyrimidine in accordance with carA420 
regulation in E. coli. 421 
We also determined that CbsR12 binds to metK transcripts and downregulates production of 422 
C. burnetii MetK protein (see Figs. 5, 8, 9B). MetK is a key component of the methionine cycle,423 
which converts methionine to SAM via MetK, SAM to S-adenosylhomocysteine (SAH) via424 
various methylases, SAH to homocysteine via AhcY, and homocysteine to methionine via 425 
MetH/MetE. Cells produce homocysteine as an input molecule through a series of reactions426 
involving activated homoserines (reviewed in (59)). C. burnetii is a semi-auxotroph for427 
methionine, since it can potentially grow without methionine in axenic media, albeit at a slower428 
growth rate (60). Interestingly, C. burnetii lacks several components of the methionine synthesis429 
pathway, most notably the ability to produce activated homoserines. Most bacteria activate430 
homoserine through addition of an O-succinyl group catalyzed by MetA or an O-acetyl group431 
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catalyzed by MetX (reviewed in (59)). C. burnetii apparently lacks genes coding for these 432 
enzymes. An ABC methionine transporter has been hypothesized (60) but not verified in433 
Coxiella. If this is indeed a functional transporter, CbsR12’s negative regulation of metK434 
transcripts makes sense in the context of the sRNA’s high level in LCVs, because any amount of435 
scavenged methionine would be critical to growth. Shifting the equilibrium from SAM synthesis436 
to methionine retention would be necessary as C. burnetii rapidly produces proteins to expand its437 
intracellular niche. 438 
SAM is a major methyl donor, is necessary for regulation of numerous enzymes, and has439 
been implicated as a major contributor to virulence (61, 62). Some bacteria lack metK and440 
instead transport SAM directly (63). There are many uncharacterized transporters encoded in the441 
C. burnetii genome, so it is conceivable that a SAM transporter is present (57). This would allow442 
for SAM scavenging even when MetK production is downregulated by CbsR12. Furthermore, if 443 
SAM transport occurs, C. burnetii could synthesize methionine without having to scavenge it,444 
since the amino acid can be synthesized from SAM without activated homoserine via the445 
methionine cycle. 446 
We also determined that CbsR12 actively targets ahcY transcripts (see Fig. 6). AhcY is a 447 
component of the methionine cycle and catalyzes conversion of SAH into homocysteine and448 
adenosine. Based on the location of the CbsR12-binding site in the coding region of the ahcY449 
transcript (Fig. 6 inset), we predict that CbsR12 negatively regulates AhcY translation. The450 
underlying reason for this negative regulation is unknown, although it could help to suppress451 
adenosine and/or homocysteine accumulation in LCVs. 452 
cvpD mRNA was also identified as a CbsR12 target through Crosslink-Seq (see Fig. 6), and453 
this was confirmed by RNA-RNA hybridization / EMSA and qRT-PCR analyses (see Figs. 5,454 
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S6C). In this study, we found that CbsR12 was necessary for CCV expansion in early stages of a455 
THP-1 infection. The mechanism for this is unclear, although it may involve regulation of cvpD,456 
which is required for C. burnetii’s intracellular replication and CCV expansion in infected THP-457 
1 and HeLa cells (9). CbsR12 is predicted to target the coding region of the cvpD transcript and458 
would negatively regulate translation. However, in the context of cbsR12’s expression pattern, 459 
this is an unclear association, as one would expect upregulation of CvpD synthesis at a time460 
when CbsR12 is highly produced in LCVs. However, 5' RACE analysis of cvpD transcripts in461 
MB-WT and MB-cbsR12 provides a potential explanation, as an alternative cvpD promoter462 
downstream of the CbsR12-binding site occurs that also possesses a putative RBS and start463 
codon (see Fig. S6A). From these results, we hypothesize that there are two gene isoforms of464 
cvpD that are transcribed and differentially expressed depending on the C. burnetii morphotype.465 
Due to high expression of cbsR12 in LCVs, the longer cvpD transcript isoform would be466 
downregulated by RNase III. As expression of cbsR12 decreases as the infection proceeds, the467 
longer transcript isoform would accumulate. qRT-PCR data support this explanation, since a lack 468 
of CbsR12 in MB-cbsR12 significantly increased the quantity of long cvpD isoform transcripts 469 
(see Fig. S6C). This hypothesis could be confirmed if the two putative CvpD products could be470 
identified and distinguished.  471 
The 2007-2010 Dutch outbreak involving C. burnetii yielded several newly annotated 472 
genomes specific to that epidemic (64). Curiously, 7 of 13 strains analyzed contained a473 
frameshift deletion in cvpD, leading to premature stop codons (64). Among these, strains 18430474 
(NZ_CP014557.1), 14160-001 (NZ_CP014551.1), 701CbB1 (NZ_CP014553.1), and 2574475 
(NZ_CP014555.1) had single-base deletions that only affected the long cvpD isoform. These476 
strains were isolated from aborted placentas of ruminants and cattle in the Netherlands and477 
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France (64). Additional related strains include the Heizberg (NZ_CP014561.1), Henzerling 478 
(NZ_CP014559.1), and RSA 331 (NC_010117.1). These strains, which were isolated from 479 
patients with acute Q fever in northern Italy and Greece in the mid 1900’s, harbored 4-bp 480 
frameshift deletions near the middle of the cvpD coding region, affecting both long and short 481 
cvpD isoforms and introducing premature stop codons (64, 65). Apparently, CvpD was 482 
dispensable for virulence in the latter strains, whereas the Dutch outbreak strains harbored intact 483 
cvpD genes, or cvpD genes with a 1-bp frameshift deletion only affecting the longer gene 484 
isoform. Thus, in these Dutch isolate strains it appears that CbsR12 regulation of cvpD is 485 
dispensable. Granted, there are many genotypic differences between RSA439 and the Dutch 486 
isolates (64), and some compensatory mechanism(s) may exist for the absence of cvpD. 487 
Alternatively, cvpD may be necessary during infection of human cell lines and dispensable in 488 
host-animal infections. Regardless, the role and regulation of the CvpD effector requires further 489 
investigation. 490 
 cbsR12's high level of expression during infection likely facilitates and regulates the many 491 
functions we have described. CbsR12 not bound to CsrA-2 presumably acts in trans to facilitate 492 
efficient replication through translational up-regulation of CarA and down-regulation of MetK, 493 
and perhaps potentiates expansion of the CCV by means of cvpD transcript regulation. 494 
Furthermore, regulation is most likely independent of CsrA, because these genes lack multiple 495 
CsrA-binding sites necessary for regulation (see Table 3). It is worth noting that the CsrA-496 
binding sites of CbsR12 do not overlap with metK and cvpD binding sites. Hence, it is feasible 497 
that CbsR12 may still regulate metK and cvpD in trans while bound to CsrA-2; in fact, a 498 
chaperone-like function such as this has recently been ascribed to CsrA (66).  499 
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CbsR12 is one of only a few identified trans-acting sRNAs that also binds CsrA (reviewed 500 
in (67)). We hypothesize that CbsR12’s role in regulating C. burnetii replication and CCV 501 
expansion is due to a combination of in-trans mRNA (metK, carA, cpvD) targeting and 502 
regulation of CsrA-2 function. Our lab is currently working to elucidate the CsrA-1/CsrA-2 503 
regulons, along with regulation of the putative CbsR12-CsrA-2 cascade of C. burnetii and the 504 
nature of CsrA-CbsR1 binding to clarify the interplay between CbsR12’s roles as a trans-acting 505 
and CsrA-sequestering sRNA. 506 
 507 
Materials and Methods 508 
Bacterial strains, cell lines and growth conditions 509 
Strains, primers, and plasmids used in this study are listed in Fig. S10. E. coli was grown in 510 
lysogeny broth (LB) supplemented with ampicillin (100 µg/mL) or kanamycin (50 µg/mL), as 511 
needed. When necessary, overnight cultures were expanded to 100 mL LB, grown for 2 h, then 512 
supplemented with 1 mM IPTG for induction. C. burnetii Nine Mile phase II (strain RSA439, 513 
clone 4), MB-WT, MB-cbsR12, and MB-cbsR12-Comp were grown in ACCM-2 medium (37) 514 
supplemented with ampicillin (5 µg/mL) or kanamycin (350 µg/mL) at 5% CO2, 2.5% O2, 92.5% 515 
N2 37°C, and 100% humidity with continuous shaking at 75 RPM (37). SCVs collected from 516 
Vero cells were used for all C. burnetii infections and growth curve experiments. Briefly, C. 517 
burnetii was used to infect Vero cell monolayers for 7d at 5% CO2 and 37°C, after which the 518 
cultures were removed to room temperature and the flask lids tightened and covered for two 519 
additional weeks (68). Following this, SCVs were harvested with digitonin, as previously 520 
described (69).  521 
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24 
African green monkey kidney (Vero) epithelia (CCL-81; American Type Culture Collection;522 
ATCC) and human monocytic leukemia (THP-1) cells (TIB-202; ATCC) cell lines were 523 
maintained in RPMI medium (Gibco) supplemented with 10% fetal bovine serum (FBS,524 
RMBIO) in a humidified atmosphere with 5% CO2 at 37°C. THP-1 cells were differentiated to525 
macrophages by supplementing the growth medium with 200 nM phorbol myristate acetate526 
(PMA, Sigma) overnight.  527 
Plasmid construction 528 
pBESTluc was used as a backbone for all reporter assay constructs and was included in the529 
Luciferase Assay System kit (Promega). pBEST + metK was created by inserting nucleotides530 
corresponding to the first 10 codons of C. burnetii metK immediately downstream of the luc start531 
codon using a Q5 Site-Directed Mutagenesis Kit, as instructed (New England Biolabs). cbsR12 532 
was cloned into pBESTluc using primers containing XhoI and AfeI restriction sites on the 533 
forward and reverse primers, respectively. The forward primer also encoded a Ptac promoter and534 
lac operator. The PCR product was cloned into pBEST + metK using unique XhoI and AfeI 535 
restriction sites in an irrelevant intergenic region. A frameshifted luc construct was created as a 536 
byproduct of the metK Q5 mutagenesis of pBESTluc and contained a 1-bp frameshift deletion in 537 
the 5' end of luc. PBEST + carA 5' UTR was created using primers specific to the 5' UTR of538 
carA with HindIII and BamHI restriction sites on the forward and reverse primers, respectively.539 
The forward primer also encoded the Ptac promoter. Nucleotides corresponding to the lac 540 
operator were inserted using a Q5 Site-Directed Mutagenesis Kit to create the final pBEST +541 
carA 5' UTR construct. The cbsR12 gene was inserted into this construct in the same fashion as 542 
for pBEST + metK + cbsR12. 543 
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25 
Recombinant CarA and MetK were generated by PCR amplification of carA and metK using 544 
forward and reverse primers containing BamHI and HindIII restriction sites, respectively. The545 
resulting amplicons were cloned into compatible restriction sites of pQE30 (Qiagen) by standard546 
protocol. 547 
Axenic growth of C. burnetii 548 
For growth curves and Crosslink-Seq experiments, 3.33 x 10
4 
genomic equivalents (GE)/mL of549 
MB-WT, MB-cbsR12, or MB-cbsR12-Comp were inoculated into 300 mL ACCM-2 in a 1-liter550 
flask with either chloramphenicol (5 μg/mL), kanamycin (350 μg/mL) or both. GE/mL was551 
initially determined from frozen cell stocks by qPCR as previously described (68), although552 
different dotA primers were used (Fig. S10). Cell viability was determined using a BacLight 553 
Bacterial Viability kit as instructed (Thermo Scientific). 554 
C. burnetii infection of differentiated THP-1 cells 555 
THP-1 cells were seeded onto 4-well chambered glass slides (Labtek) or T-75 flasks. After 2d of 556 
growth, 200 nM PMA was added along with fresh medium and cells were allowed to 557 
differentiate overnight. The PMA-supplemented medium was removed and fresh medium 558 
restored, after which differentiated THP-1 cells were allowed to recover for 4 h prior to C.559 
burnetii infection at an MOI of 10. Initial infections were rocked for 2 h at room temperature 560 
before returning cells to 5% CO2 and 37°C. At 1dpi the supernatant was removed, extracellular561 
C. burnetii was washed away with warmed 1X PBS, and fresh medium was added. 562 
Total RNA and genomic DNA extraction and purification 563 
C. burnetii grown in ACCM-2 was centrifuged at 15,000 x g at 4°C for 15 min, after which564 
pellets were resuspended in 1 mL TRI Reagent (Ambion). The suspension was incubated for 1 h565 
at room temperature, frozen for 2 h at -80°C, thawed for 30 min at room temperature, then566 
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pipetted vigorously until homogenized. 100 µL BCP (Acros Organics) was added, the solution567 
vortexed for 30 sec, incubated for 5 min at room temperature, and centrifuged at 12,000 x g at 568 
4°C for 10 min. The aqueous phase was then collected and 300 µL 100% ethanol added. The569 
mixture was immediately vortexed for 10 sec, and a RiboPure RNA Purification kit (Ambion) 570 
was used to collect, concentrate, and wash the resulting RNA. RNA was collected in nuclease-571 
free H2O and treated with DNase I for 1 h at 37°C. After RNA precipitation in 100% ethanol, the572 
purified RNA was run on a NanoDrop spectrophotometer (Thermo Scientific) to determine 573 
concentration and purity. 574 
In order to purify total RNA from C. burnetii grown in THP-1 cell lines, growth medium 575 
was first removed and replaced with 1 mL TRI Reagent. Flasks containing TRI Reagent were576 
rocked for 1 h at room temperature, after which cells were mechanically scraped and collected577 
into a 15-mL conical tube. The mixture was frozen overnight at -80°C, thawed to room578 
temperature for 30 min, and the RNA purification procedure continued as described above. 579 
Genomic DNA was purified from TRI Reagent mixtures according to manufacturer 580 
protocols (Ambion). The resulting DNA was purified using a Nucleotide Removal kit as581 
instructed (Qiagen). 582 
Quantitative PCR (qPCR) and quantitative real-time PCR (qRT-PCR) 583 
qPCR and qRT-PCR experiments were performed as previously described (69) using 300 nM of584 
primers specific to cbsR12 and a volume of iQ SYBR Green Supermix (Bio-Rad). The resulting585 
reactions were cycled on a MyiQ Single-Color Real Time PCR Detection System (version 1.0586 
software) (Bio-Rad). CbsR12 cDNA copy number was normalized against dotA copy number587 
derived from C. burnetii genomic DNA to obtain copy numbers / GE values. Growth curve588 
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GE/mL and GE/flask values were obtained from genomic DNA purified from the same cells 589 
from which total RNA was purified.  590 
For ACCM-2 growth curves, 30 mL aliquots of a 300-mL culture were removed at each time 591 
point. gDNA was extracted and resuspended in 30 μL nuclease-free H2O. 1 μL gDNA was used 592 
in subsequent qPCR reactions producing GE/mL values. For THP-1 growth curves, 8 separate T-593 
75 flasks for each C. burnetii strain tested were inoculated simultaneously. At the specified time 594 
point, one flask was taken and 30 μL gDNA was again extracted. 1 μL gDNA was used in 595 
subsequent qPCR reactions and the GE/flask values were calculated. Each growth curve and 596 
qPCR reaction were performed in triplicate. 597 
RNase III assay 598 
RNase III assays were performed as previously described (43) using 200 nM CbsR12 substrate 599 
and the C. burnetii intervening sequence (IVS) RNA as a positive control (43). Resulting 600 
reactions were electrophoresed on a 7% denaturing polyacrylamide gels and stained with 2 601 
μg/mL acridine orange to visualize bands. 602 
Identification of transcription start sites 603 
5' RACE analysis of carA, metK, cvpD, and cbsR12 transcripts was performed on MB-WT and 604 
MB-cbsR12 RNA extracted from infected Vero (cbsR12, carA, and metK) or THP-1 (cvpD) cells 605 
at 3dpi using a 5' RACE System kit (Invitrogen) according to manufacturer protocols and with 606 
gene-specific primers (see Fig. S10). Resulting PCR products were cloned into pCR2.1-TOPO as 607 
instructed (Invitrogen) and then sequenced with M13 universal primers by Sanger automated 608 
sequencing. In general, three biological replicate total RNA samples were obtained from MB-609 
WT and MB-cbsR12 infections of Vero and THP-1 cells. From these pools, 5' RACE was 610 
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performed as above and 4 clones from each replicate were sequenced, producing 12 total clones611 
analyzed for each total RNA pool for each gene analyzed. 612 
In silico and bioinformatics analyses 613 
RNA target predictions were carried out using TargetRNA2 (70), IntaRNA (71), and CopraRNA614 
(72) algorithms with default settings. RNA was folded using mFold (73) and visualized with615 
Visualization Applet for RNA (74). Analyses of RNA-Seq data were carried out as previously616 
described (38). Briefly, raw fastq files were concatenated, quality-filtered with the FASTX617 
toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) then clipped, aligned, and filtered with Nesoni618 
version 0.128 tools (http://www.vicbioinformatics.com/software.nesoni.shtml). Transcripts per619 
million (TPM) were calculated using custom perl and python scripts that can be accessed through 620 
GitHub (https://github.com/shawachter/TPM_Scripts). Crosslink-Seq enrichment was621 
accomplished by processing .bam files using featureCounts (75), followed by use of the DESeq2622 
package in R version 3.4.4 to obtain differentially expressed genes (76). The Artemis genome623 
browser was used to visualize generated alignment files624 
(http://www.sanger.ac.uk/science/tools/artemis) (77). 625 
All IFA images were processed and analyzed using Fiji (78) and Cell Profiler (79),626 
respectively. Figures were created using R version 3.4.4, Inkscape627 
(https://inkscape.org/release/inkscape-0.92.4/) and GIMP (https://www.gimp.org/downloads/). 628 
RNA-RNA hybridization and EMSA 629 
Regions of target genes were first selected for PCR amplification. The following regions were630 
chosen based on inclusion of predicted 5’ UTRs and CbsR12-binding sites (+1 nucleotide631 
designation is the first nucleotide of the annotated start codon): carA (-143) – (-1), metK (-26) – 632 
(+110), cvpD (-41) – (+101), purH (-100) – (+44), dnaA (-97) – (+61), and rpsA (-65) – (+77).633 
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PCR products (1g) of desired templates were in vitro-transcribed overnight at 37°C with 2.5634 
mM Ribonucleotide Solution Mix (New England Biolabs) and when needed, 0.5 mM Bio-16-635 
UTP (Invitrogen) using a MAXIscript T7 Transcription kit (Invitrogen). Resulting reactions were 636 
incubated for 1 h at 37
o
C with 1 µL TURBO DNase (Invitrogen), heated for 4 min at 85°C then637 
immediately plunged in ice, and electrophoresed on a 7% polyacrylamide gel for 75 min at638 
100V. Gels were stained with a 2 μg/mL acridine orange solution and visualized bands were639 
excised and eluted overnight into probe elution buffer (0.5M AmAc, 1mM EDTA, 0.2% SDS) at 640 
37°C. The resulting solution was precipitated with ethanol overnight at -20
 o
C, washed with 70%641 
ethanol, and resuspended in nuclease-free H2O. RNA concentrations were determined using a642 
NanoDrop spectrophotometer. Following this, 10 nM biotin-labeled CbsR12 and, unless643 
otherwise noted, 5 nM target RNA were combined and heated for 5 min at 85°C. A high-salt 644 
TMN buffer (100 mM NaCl, 50 mM MgCl2, 100 mM Tris-Cl, 0.05% Tween-20) was then added645 
and reactions were immediately plunged on ice for 30 sec and then incubated for 30 min at 37
o
C.646 
A non-denaturing loading dye (0.25% bromophenol blue) was added and the resulting RNA647 
mixtures were resolved on a 7% polyacrylamide gel for 1 h 20 min at 100V. RNA was648 
transferred to a BrightStar-Plus Positively Charged Nylon Membrane (Ambion) using an electro-649 
blot transfer system (Bio-Rad) and cross-linked with short-wave UV light in a GS Gene Linker 650 
UV Chamber (Bio-Rad). A North2South Chemiluminescent Hybridization and Detection Kit651 
(Thermo Scientific) was used to detect resulting bands. The blot was imaged on a LAS-3000652 
imaging system (Fujifilm). 653 
RNA-protein electrophoretic mobility shift assay 654 
CbsR12-CsrA1/2 EMSAs were performed as previously described for CsrA-binding RNAs (44).655 
Biotin-labeled CbsR12 was synthesized in vitro as above for RNA-RNA EMSAs. C. burnetii 656 
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30 
csrA-1 and csrA-2 genes were cloned into pQE30, expressed, and resulting proteins natively657 
purified as previously described (43). 1 nM biotin-labeled CbsR12 diluted in TE buffer (10mM658 
Tris-HCL, 1mM EDTA) was heated at 75°C for 3 min and equilibrated to room temperature for659 
10 min. Purified CsrA1/2 diluted in CsrA-binding buffer (1 µl in 10mM Tris-HCl, 10mM MgCl2,660 
100mM KCl, 10mM DTT, 10% glycerol, and 10 U RNasin [Promega]) was added, and reactions661 
were incubated for 30 min at 37°C. Samples were immediately resolved on 10% non-denaturing662 
polyacrylamide gels for 3h. Membrane transfer and imaging were performed as in RNA-RNA663 
EMSAs described above. The KD for CsrA-2 was determined as previously described (44). 664 
Reporter assay 665 
A Luciferase Assay System kit (Promega) was used. All pBESTluc constructs were transformed666 
into E. coli Top 10 F'. Resulting E. coli strains were grown overnight at 30°C in 10 mL LB 667 
containing ampicillin (100 µg/mL) and 1% glucose in order to mitigate the autoaggregative668 
effects of CbsR12. An aliquot (4.5 mL) of the overnight culture was inoculated into 40.5 mL LB 669 
with 100 µg/mL ampicillin and grown for 1.5 h at 30°C. IPTG was added (to 1 mM) and culture 670 
aliquots (100 l) were removed at 0, 1, and 2 h time points. 80 µL LB and 20 µL CCLR lysis671 
solution (1X CCLR, 25 mg BSA, 12.5 mg lysozyme, 7.5 mL water) were added to the aliquots 672 
and gently inverted until the solution clarified. 50 µL of the resulting lysate was aliquoted to a 673 
96-well plate, 100 µL of luciferase assay substrate was added, and luminescence was674 
immediately read with a SpectraMax M5 Plate Reader (Molecular Devices). 675 
Crosslink-Seq analysis 676 
RNA-RNA crosslinking was performed essentially as previously described (47, 80), except TRI677 
Reagent was utilized for total RNA extraction as described above and 10 nmol of two distinct 678 
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31 
biotinylated in vitro-transcribed anti-CbsR12 RNAs were used as probes. The resulting captured 679 
RNA was sent to the Yale Center for Genomic Analysis for RNA-Seq analysis. 680 
Immunofluorescence assay 681 
IFAs on infected THP-1 cells were performed as previously described with modifications (11).682 
Briefly, 4-well chambered glass slides were coated for 30 min with a 0.2% solution of Sigmacote683 
(Sigma). THP-1 cells were inoculated into chambered slides and incubated overnight or until684 
60% confluence was reached and then differentiated with 200 nM PMA. Confluent cells were 685 
then infected with MB-WT, MB-cbsR12, or MB-cbsR12-Comp strains at a MOI of 10. At 1dpi,686 
infections were stopped by washing cells three times for 5 min in pre-warmed 1X PBS, after 687 
which fresh medium was added. At 3 or 7 dpi, the growth medium was removed and cells were688 
fixed with ice-cold 100% methanol for 5 min at room temperature. Cells were washed three689 
times for 5 min each with ice-cold 1X PBS, blocked for 1 h at room temperature with a 2% BSA 690 
solution in 1X PBS, and then incubated with anti-Com1 (1:1000) and anti-LAMP1 (1:50, H4A3691 
was deposited to the Developmental Studies Hybridoma Bank by August, J.T / Hildreth, J.E.K)692 
antibodies for 2 h. Cells were washed and incubated with Alexa Fluor 488 (1:200, Thermo693 
Scientific) and goat anti-mouse rhodamine antibodies (1:200, Thermo Scientific) along with694 
DAPI (300 nM, Thermo Scientific) for 1 h. Cells were then washed three times for 5 min each in 695 
ice-cold 1X PBS and immediately imaged. Images were processed with Fiji (78). Cell Profiler696 
was used to measure CCV areas, as previously described (81). Measurements were taken from 697 
46 individual images of random fields of view spanning three different experiments for each C.698 
burnetii strain. 699 
Protein synthesis, purification and antibody production 700 
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Recombinant Coxiella RNase III was synthesized from a previously-generated pQE30 construct 701 
and purified as before (43). C. burnetii carA and metK genes were cloned in-frame into pQE30 702 
(Qiagen) and the resulting N-terminal His6-tagged proteins synthesized and purified as 703 
previously described for C. burnetii RNA helicase (82). Purified recombinant CarA and MetK 704 
proteins were submitted to General Bioscience, Inc., for rabbit polyclonal antibody production. 705 
Western blot 706 
Western blots were performed as previously described (36) with minor modifications. MB-WT, 707 
MB-cbsR12, and MB-cbsR12-Comp strains were grown to mid-log phase (4 d for MB-WT and 708 
MB-cbsR12-Comp, 6 d for MB-cbsR12) in ACCM-2. Proteins at 30 µg (CarA blot) or 60 µg 709 
(MetK blot) were resolved on 10% - 20% acrylamide gradient Tris-Glycine SDS-PAGE gels. 710 
Duplicate gels were run in parallel for Coomassie brilliant blue staining (CBB; 0.1% (w/v) in 711 
50% methanol, 7% (v/v) acetic acid) in order to present a loading control. Blots were incubated 712 
with primary antibody solution (1X PBS pH7.4, 0.3% (v/v) Tween-20, 1:500 CarA / 1:5000 713 
MetK primary antibody) for 2 h with rocking at room temperature. Blots were washed five times 714 
for 5 min in 1X PBS, then incubated for 1 h in secondary antibody solution (1X PBS + 1:2000 715 
goat anti-rabbit::HRP). Blots were again washed five times for 5 min in 1X PBS and 716 
immediately developed using SuperSignal West Pico Chemiluminescent Substrate (Thermo 717 
Scientific) according to the manufacturer's protocol. Imaging was performed on a ChemiDoc 718 
XRS+ System (Bio-Rad). 719 
E. coli biofilm induction assay 720 
E. coli biofilm induction assays were performed as previously described (33). 96-well plates 721 
were inoculated with an overnight culture of either pBEST or pBEST + carA 5’ UTR + cbsR12 722 
E. coli strains (see Fig. S10). Cultures were allowed to grow for 3 h until induction with 1mM 723 
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IPTG, after which cultures were allowed to grow an additional 21 h before subsequent staining 724 
with crystal violet. The average OD570 readings of 10 wells were obtained by spectrophotometry.  725 
Generation of a CbsR12-complemented strain 726 
MB-cbsR12 was complemented as previously described, with modifications (83). Briefly, wild-727 
type cbsR12 along with 100 bp of flanking sequences were PCR-amplified using primers 728 
containing EcoRI and BamHI restriction sites. The amplicon was cloned into compatible 729 
restriction sites of pMini-Tn7-KAN by standard protocol (84). The resulting plasmid was 730 
transformed into electrocompetent E. coli PIR1 cells for propagation. The pMini-Tn7-CbsR12-731 
KAN plasmid (20 g), along with 10 g of a second plasmid containing the transposase, pMini-732 
TnS2-ABCD, were transformed into MB-cbsR12 in a single electroporation reaction (25 kV, 500 733 
ohms, 25 F). Electroporated cells were allowed to recover 5 d in ACCM-2 supplemented with 734 
1% FBS, then dilutions were plated onto ACCM-2 agar containing kanamycin (375 g/mL). 735 
Isolated colonies were picked and re-cultured on ACCM-2 agar plates for several rounds. 736 
Colony-PCR was used to screen for the MB-cbsR12-Comp strain, and the location of the cbsR12 737 
cassette was determined by PCR and Sanger automated sequencing. qPCR of MB-cbsR12-Comp 738 
genomic DNA utilizing primers specific to cbsR12 was used to ensure that a single transposon 739 
insertion event occurred. 740 
Data availability 741 
The sequencing reads from the Crosslink-Seq experiments are available at the NCBI sequencing 742 
read archive (accession number: PRJNA522455). 743 
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 984 
FIGURE LEGENDS 985 
Fig 1. CbsR12 binds to CsrA-2, but not CsrA-1, protein in vitro. EMSAs showing RNA-986 
protein interactions between biotin-labeled, in vitro-transcribed CbsR12 (0 or 1 nM) and 987 
increasing concentrations of purified, rCsrA-1 (A) or rCsrA-2 (B). CbsR10 (at 0 or 1 nM; right 988 
of vertical black line) is included as a negative control, as the sRNA contains only a single 989 
discernible CsrA-binding motif. 990 
Fig 2. CbsR12 production and growth effects on C. burnetii grown in ACCM-2. (A). Growth 991 
curves for MB-WT, MB-cbsR12, and MB-cbsR12-Comp in ACCM-2 as determined by qPCR. 992 
The 0dpi time point refers to the inoculum. Values represent the means ± standard error of means 993 
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(SEM) of three technical replicates. Data are representative of three independent experiments 994 
with consistent and indistinguishable results. (B).CbsR12 production over time for MB-WT, 995 
MB-cbsR12, and MB-cbsR12-Comp grown in ACCM-2 as determined by qRT-PCR. Values 996 
represent the means ± standard error of means (SEM) of three independent determinations. 997 
Fig 3. CbsR12 production and growth effects on C. burnetii infecting THP-1 cells. (A). 998 
Growth curves for MB-WT, MB-cbsR12, and MB-cbsR12-Comp in THP-1 cells as determined 999 
by qPCR. The 0dpi time point refers to the inoculum. Values represent means ± standard error of 1000 
means (SEM) of three technical replicates. Data are representative of three independent 1001 
experiments with consistent and indistinguishable results. (B). Cbsr12 production over time for 1002 
MB-WT, MB-cbsR12, and MB-cbsR12-Comp infecting THP-1 cells, as determined by qRT-1003 
PCR. Values represent means ± standard error of means (SEM) of three independent 1004 
determinations. 1005 
Fig 4. CbsR12 affects CCV expansion in infected THP-1 cells. (A). Representative IFAs of 1006 
MB-WT, MB-cbsR12 and MB-cbsR12-Comp infecting THP-1 cells at 3dpi and 7dpi. C. burnetii 1007 
was probed with anti-Com1 antibodies coupled to Alexa Fluor 488 (green), CCV boundaries 1008 
were labeled with anti-LAMP1 antibodies coupled to rhodamine (red), and host cell nuclei were 1009 
labeled with DAPI (blue). (B). Sizes of individual CCVs in log10(pixels) for MB-WT, MB-1010 
cbsR12, and MB-cbsR12-Comp. Measurements were taken from 46 individual images of random 1011 
fields of view spanning three different experiments for each C. burnetii strain. Crossbars 1012 
represent means ± standard error of means (SEM) (** = P < 0.01, one-way ANOVA). Scale bars 1013 
= 20 µm. 1014 
Fig 5. CbsR12 targets carA, metK, and cvpD transcripts in vitro. RNA-RNA EMSA showing 1015 
hybridization reactions with 10 nM biotin-labeled CbsR12 and 5 nM in vitro-transcribed 1016 
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segments of carA, metK, cvpD, purH, rpsA or dnaA. Anti-CbsR12 represents a 10 nM positive 1017 
control consisting of a transcript equal in size, but antisense, to the CbsR12 transcript. Arrows 1018 
indicate un-bound bio-CbsR12 (blue) and bio-CbsR12 bound to RNA targets (red). 1019 
Fig 6. CbsR12 targets several C. burnetii transcripts, including those of metK, carA and 1020 
cvpD. Volcano plot highlighting mRNAs that occur at different levels between Crosslink-Seq 1021 
experiments with strains MB-WT and MB-cbsR12. Labeled transcripts are indicated by a green 1022 
dot and are significantly enriched in MB-WT versus MB-cbsR12, identifying them as targets of 1023 
CbsR12. Black dots represent transcripts not significantly different between the strains tested. 1024 
Orange dots represent transcripts having a log2-fold change > 1, but a false discovery rate (FDR) 1025 
> 0.05. There were no transcripts indicated by red dots, which would represent mRNAs with a 1026 
FDR < 0.05 but a log2-fold change in levels < 1. Data shown are representative of two biological 1027 
replicates each of MB-WT and MB-cbsR12 Crosslink-Seq experiments. The potential CbsR12-1028 
binding site in the coding region of the ahcY transcript is inset. 1029 
Fig 7. CbsR12 targets and upregulates translation of a carA-luciferase fusion construct. 1030 
(A). Secondary structure of the carA 5' UTR as predicted by mFold. Red asterisks indicate TSSs 1031 
for the shorter transcripts as determined by 5' RACE. (Nucleotide 1 was determined to be the 1032 
TSS for the full-length transcript by 5' RACE). Colored lines represent the start codon (green), 1033 
predicted RBS (red), and determined CbsR12-binding sites (blue). (B). Representation of 1034 
CbsR12 binding to the carA transcript as determined by IntaRNA, with respective base numbers 1035 
indicated. The top strand in the model represents the carA sequence, while the bottom strand 1036 
represents the complementary CbsR12 sequence. (C). carA-luc reporter assay indicating relative 1037 
luminescence units produced by pBESTluc constructs with: 1) no luciferase production 1038 
(Frameshifted Luciferase), 2) pBESTluc vector (pBEST), 3) pBESTluc with the carA 5' UTR 1039 
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upstream of luc but lacking cbsR12 (pBEST + carA 5' UTR), and 4) carA 5' UTR upstream of 1040 
luc plus the cbsR12 gene driven by a Ptac promoter (pBEST + carA 5' UTR + cbsR12). Values 1041 
represent means ± standard error of means (SEM) of three independent determinations (* = P < 1042 
0.05, student's t test). 1043 
Fig 8. CbsR12 targets and downregulates translation of a metK-luciferase fusion construct. 1044 
(A). Secondary structure of the metK 5' UTR and initial coding sequence as predicted by mFold. 1045 
Red asterisks indicate apparent alternative “TSSs” determined by 5' RACE. (Nucleotide 1 was 1046 
determined to be the TSS for the full-length transcript by 5' RACE). Colored lines represent the 1047 
start codon (green), a predicted RBS (red), and the determined CbsR12-binding site (blue). (B). 1048 
Representation of CbsR12 binding to the metK transcript as determined by IntaRNA with base 1049 
numbers indicated. The top strand in the model represents the metK sequence, while the bottom 1050 
strand represents the complementary CbsR12 sequence. (C). metK-luc reporter assay indicating 1051 
relative luminescence units produced by pBESTluc constructs with: 1) no luciferase production 1052 
(Frameshifted Luciferase), 2) pBESTluc vector (pBEST), 3) pBESTluc with the CbsR12 binding 1053 
site cloned in-frame into luc but lacking the cbsR12 gene (pBEST + metK) and 4) pBESTluc 1054 
with the CbsR12 binding site cloned in-frame into luc plus the cbsR12 gene driven by a Ptac 1055 
promoter (pBEST + metK + cbsR12). Values represent means ± standard error of means (SEM) 1056 
of three independent determinations (* = P < 0.05, student's t test). 1057 
Fig 9. CarA and MetK proteins are differentially synthesized in MB-WT, MB-cbsR12, and 1058 
MB-cbsR12-Comp strains. (A). Proteins (30 µg total) from MB-WT, MB-cbsR12, and MB-1059 
cbsR12-Comp LCVs (mid-log phase; 96h for MB-WT and MB-cbsR12-Comp and 144h for MB-1060 
cbsR12) grown in ACCM-2 were resolved on a 10-20% acrylamide gradient SDS-PAGE gel, 1061 
blotted, probed with rabbit anti-CarA antibodies, and detected with chemiluminescence. The 1062 
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black arrow indicates CarA. (B). Proteins (60 µg total) from MB-WT, MB-cbsR12, and MB-1063 
cbsR12-Comp LCVs (mid-log phase; 96h for MB-WT and MB-cbsR12-Comp and 144h for MB-1064 
cbsR12) grown in ACCM-2 were resolved on a 10-20% acrylamide gradient SDS-PAGE gels, 1065 
blotted, probed with rabbit anti-MetK antibodies, and detected with chemiluminescence. The 1066 
black arrow indicates MetK.  1067 
 1068 
Table 1. Top ten expressed genes
a
 across various C. burnetii growth conditions, ranked. 1069 
Rank ACCM-2b LCV 
(3dpi) 
ACCM-2
 b
 SCV 
(21dpi) 
Vero LCV 
(3dpi) 
Vero SCV 
(21dpi) 
THP-1 LCV 
(3dpi) 
1 tmRNA 
(104,383) 
tmRNA (4,430) tmRNA 
(153,422) 
tmRNA 
(22,500) 
tmRNA 
(128,928) 
2 CBU_1183 
(32,842) 
Intergenic 
(2,632) 
CbsR12 
(79,870) 
CbsR12 
(8,521) 
RNase P RNA 
(63,637) 
3 CBU_0307 
(13,902) 
CBU_1538 
(2,133) 
RNase P RNA 
(25,715) 
CBU_0089a 
(8,012) 
CbsR12 
(33,331) 
4 CBU_1224a 
(11,023) 
Intergenic 
(1,977) 
CBU_0089a 
(13,882) 
CBU_2034 
(4,375) 
6S RNA 
(22,540) 
5 RNase P RNA 
(10,3923) 
tRNA (1,902) CbsR1 (11,445) CBU_1170 
(3,704) 
CBU_0456 
(17,603) 
6 CBU_0311 
(7,544) 
CBU_0183 
(1,593) 
CBU_0718  
(10,370) 
CBU_0718 
(3,703) 
CBU_0474 
(16,267) 
7 CBU_0474 
(7,120) 
Intergenic 
(1,543) 
CBU_1932 
(9,734) 
CBU_1280a 
(3,522) 
CBU_1183 
(13,349) 
8 Intergenic 
(6,928) 
CBU_0157 
(1,390) 
CBU_1272 
(9,011) 
RNase P RNA 
(3,429) 
CBU_0307 
(12,753) 
9 CBU_0306 
(6,666) 
Intergenic 
(1,340) 
CBU_0711 
(5,530) 
Intergenic 
(3,340) 
CBU_0311 
(12,146) 
10 CbsR12 (3,522) Intergenic 
(1,203) 
CBU_1170 
(4,633) 
CBU_1272 
(3,134) 
CBU_0473 
(11,449) 
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a
Genes as annotated for RSA493 (NCBI Ref Seq: NC_002971.4) with corresponding transcripts 1070 
per million (TPM) values in parentheses. 
b
ACCM-2 is an axenic growth medium (37). CbsR12 is 1071 
indicated in boldface. N = 2 biological replicates per condition. 1072 
 1073 
Table 2. CbsR12 target
a
 prediction using various algorithms 1074 
Rank TargetRNA2 IntaRNA CopraRNA 
1 CBU_1041 (0.001) cvpD (0.000017) cvpD (0.00001) 
2 prlC (0.001) CBU_0537 (0.00018) CBU_0537 (0.000039) 
3 suhB (0.001) CBU_1161 (0.00018) CBU_0922 (0.00053 
4 mutS (0.002) CBU_0922 (0.00091) CBU_0103 (0.00074) 
5 bioD (0.003) CBU_2028 (0.0012) CBU_2028 (0.00078) 
6 trmD (0.003) CBU_0103 (0.0013) rpsA (0.0013) 
7 dnaA (0.005) rpsA (0.0022) metK (0.0014) 
8 yciL (0.007) metK (0.0023) purH (0.0019) 
9 metK (0.008) purH (0.003) CBU_1741 (0.0025) 
10 CBU_0558 (0.01) carA (0.015) carA (0.0067) 
a
Target genes identified through algorithms, ranked. Calculated p-values for each target are 1075 
indicated in parentheses. Genes involved in subsequent experiments are indicated by bold-face 1076 
type. 1077 
 1078 
Table 3. Predicted CsrA motifs in CbsR12 targets 1079 
CbsR12 Target Gene Locus Tag
a 
Base Range
b
 CsrA Motifs
c
 Position of Motif
d
 
carA CBU_1282 c(1234872-1235073) 1 (+71) – (+75) 
metK CBU_2030 1936983-1937183 1 (-12) – (-8) 
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cvpD CBU_1818 1748916-1749116 0 N/A 
ahcY CBU_2031 1938166-1938366 2 (+1) – (+5),  
(+13) – (+17) 
a
Locus tags as annotated for RSA493 (NCBI Ref Seq: NC_002971.4).
 b
Base range indicates 100 1080 
nts up and downstream of the annotated start codon for RSA493 (NCBI Ref Seq: NC_002971.4). 1081 
c
Consensus CsrA-binding motifs are AGGA or ANGGA. 
d
Position of CsrA-binding motifs 1082 
relative to the first nucleotide of the start codon (+1). 1083 
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